Building a Validation Checklist for Internal RA Teams



Building a Validation Checklist for Internal RA Teams

Published on 19/12/2025

Building a Validation Checklist for Internal RA Teams

In the highly regulated pharmaceutical industry, ensuring that electronic Common Technical Document (eCTD) submissions meet the necessary regulatory requirements is crucial. This article provides a step-by-step guide for regulatory affairs (RA) teams to build an effective validation checklist for eCTD submissions. We will discuss eCTD validation services, validator tools, the importance of minimizing technical rejections, and best practices aligned with regulatory guidelines.

Step 1: Understand the eCTD Format Requirements

The first step in building a validation checklist is to comprehend the eCTD format requirements stipulated by regulatory bodies, particularly the FDA. The eCTD is an internationally accepted format used for electronic submissions and is crucial for both new drug applications (NDAs) and abbreviated new drug applications (ANDAs). You are mandated to follow the specifications outlined in the FDA eCTD Submission Guidance.

The eCTD is made up of five parts, or modules:

  • Module 1: Administrative information and prescribing information
  • Module 2: Common technical document summary
  • Module 3: Quality (chemistry, manufacturing, and controls)
  • Module 4: Nonclinical study reports
  • Module 5:
Clinical study reports

Each of these modules has specific requirements, including file formats (usually PDF), section order, and metadata. Understanding these components will inform the contents of your validation checklist.

Additionally, familiarize yourself with the current guidelines from the ICH. Their guidance documents offer insights into what is expected in the eCTD submission process, ensuring full compliance while minimizing the risk of technical rejections.

Step 2: Develop a Comprehensive Checklist for Module Compliance

Once you have a solid understanding of the eCTD format, the next step is to develop a comprehensive checklist to ensure compliance with each module. This checklist should include the following:

  • Document Naming Conventions: Adhere to the prescribed naming conventions specified in the regulatory guidelines. Each file should have a unique and meaningful name that reflects its content.
  • PDF File Integrity: Each PDF file should be checked to ensure that text is selectable and images are not embedded in a way that makes them unreadable by electronic systems.
  • Table of Contents: Verify the accuracy of hyperlinks within the table of contents to ensure they direct correctly to their corresponding documents.
  • Admin Files: Ensure that all required administrative files, such as the cover letter and application forms, are included in Module 1.

To facilitate adherence to these checklist components, RA teams should implement a project management tool to track compliance. This ensures that each team member is accountable and can provide documentation for their contributions.

Step 3: Implement Validator Tools for Initial Checks

Utilizing validator tools is essential for verifying that your eCTD submission meets the necessary guidelines before it is sent to the regulatory agency. There are numerous validator tools available, including software developed by third-party vendors as well as those provided by regulatory agencies themselves.

To choose an appropriate validator tool, consider the following:

  • Coverage: The tool should cover the specific regulations and standards of the FDA, EMA, and other relevant authorities.
  • Compatibility: Ensure that the tool is compatible with the version of the eCTD you are working on, including any recent updates to submission formats.
  • User Reviews: Look for user experiences and feedback regarding the tool’s accuracy and reliability.

Once a validator tool has been selected, RA teams should perform initial validations on the entire eCTD submission. These initial checks will help identify any critical issues that could result in a technical rejection. Keeping a log of validation outcomes will also assist in identifying persistent issues that need addressing in future submissions.

Step 4: Conduct Quality Reviews

Quality reviews form a critical step in the validation process for eCTD submissions. A collaborative review process among various stakeholders ensures that every aspect of the submission is scrutinized. Involve personnel from regulatory affairs, quality assurance, and subject matter experts to provide different perspectives on the submission.

The following aspects should be part of your quality review checklist:

  • Content Accuracy: Verify that all scientific data is accurate, complete, and up to date.
  • Consistency: Ensure consistency across modules, especially when referencing data and documents.
  • Formatting: Review formatting standards pertaining to font size, spacing, and margins to ensure adherence to guidelines.

Meeting regularly as a team to discuss findings from both the initial validations and quality reviews helps build a culture of compliance and continuous improvement. Maintaining documentation of reviews performed will also be valuable for future submissions and inspections.

Step 5: Prepare Documentation for Submission

After completing quality reviews and all necessary validations, the next step is to prepare your documentation for submission. Critical components for eCTD submissions include:

  • Cover Letter: A cover letter should summarize the contents of the submission and provide any necessary context to the reviewers.
  • Application Forms: Fill out all relevant forms based on the submission type and any specific requirements from the FDA.
  • Commitment Letters: If applicable, include any letters of commitment for post-approval commitments or studies.

This documentation must match the contents of the eCTD, reflecting all information accurately. Maintain clear records of all documents prepared for submission to ensure that the final package sent to the regulatory authority is complete.

Step 6: Monitor Submission Status and Address Queries

Once the eCTD has been submitted, your role is not finished. Monitoring the submission status and promptly addressing any queries from the regulatory body is essential. Use the FDA’s ClinicalTrials.gov portal to track submission status and updates related to your application.

Set up a system to track comments or queries received from the FDA or other regulatory bodies. Document all correspondence meticulously as it allows for quick resolution and provides a historical account for response strategies in future submissions.

Implement a schedule to revisit the application timeline, making sure to adhere to set deadlines for responses. This engagement with the regulatory body reinforces your dedication to a transparent submission process and can facilitate smoother communication in subsequent queries.

Step 7: Analyze Feedback and Continuous Improvement

Once your submission has been reviewed and feedback received, analyze the comments to ensure continuous improvement for future eCTD submissions. Identify common areas where issues arose, whether related to format, content, or compliance, and adjust your validation checklist accordingly.

Engage in debrief meetings with your team to discuss the experiences learned from the submission process. In these discussions, evaluate the efficiency of your validation checklist, the effectiveness of tools used, and how well the collaborative efforts of your team facilitated compliance. Documentation of these reflections will contribute to an evolving repository of lessons learned which is instrumental in future submissions.

Moreover, keep abreast of updates to regulatory guidelines. Regulatory agencies frequently evolve their submission requirements, so regular training for your team on new regulations, tools, and validation processes is crucial to maintain a competent and efficient submission team.